冠状动脉绕道手术设备市场（依产品类型、最终用户和地区）2026 年至 2032 年

冠状动脉绕道手术装置市场评估 - 2026-2032

人口老化正在推动冠状动脉绕道手术手术（CABG）设备的成长。随着年龄的增长，我们更容易罹患心臟病，包括冠状动脉疾病（CAD）。这些人口结构的变化将导致 CAD 盛行率上升，从而推动对旨在有效管理和治疗这些疾病的 CABG 手术和设备的需求。因此，老年人口的增加将倍增市场规模的成长，到2024年将超过120亿美元，到2032年将达到202.7亿美元的估值。

人们对 CAD 风险因素和早期检测重要性的认识不断提高，导致了更积极的筛检和诊断。随着社会对心臟病认识的提高，人们越来越重视早期识别风险因素并采取预防措施。这种认识的提高意味着对诊断和治疗方案（包括 CABG 设备）的需求增加。随着医疗保健系统和患者寻求先进的解决方案来解决和管理冠状动脉疾病，老龄化人口的增加加上积极主动的健康实践正在刺激 CABG 设备市场的成长。因此，对 CAD 认识的不断提高将使市场在 2026 年至 2032 年期间的复合年增长率达到 7%。

冠状动脉绕道手术装置市场定义/概述

冠状动脉绕道手术手术 (CABG) 是一种主要的医疗程序，旨在治疗冠状动脉疾病 (CAD)，其特征是冠状动脉狭窄或阻塞。这项外科手术旨在透过创造一条替代的血液循环途径来改善心肌的血流。在手术过程中，外科医生使用移植物（从患者身体的另一部分，通常是腿部或胸部取出的健康血管）来绕过冠状动脉的阻塞部分。这种旁路手术可将血液流向堵塞的动脉周围，从而改善氧气和营养物质到心肌。

进行 CABG 手术是为了恢復心臟的充足血流，对于缓解与 CAD 相关的症状（例如胸痛（心绞痛）和呼吸急促）至关重要。改善血液循环对患者有很大的好处，因为它还可以降低中风的风险并降低呼吸系统併发症的可能性。如果多条动脉被阻塞，外科医生可能会使用单一或多个移植物来达到最佳效果。

微创CABG手术因其切口少、手术时间短、恢復时间短、术后併发症风险低等优点，越来越受到人们的青睐。在微创手术中使用这些移植物可以有效解决阻塞问题并恢復心臟的健康血液流动，同时降低手术的侵入性并有助于简化手术过程。

技术创新和改善的患者结果将如何推动冠状动脉绕道手术设备市场的成长？

冠状动脉绕道手术的技术进步是这一市场扩张的前沿。机器人辅助手术和内视镜技术等创新正在改变心血管手术并显着改善患者的治疗效果。这些微创方法可减少手术创伤、加速恢復时间并提高整体手术精确度。先进的机器人医疗影像系统进一步开拓了市场，为外科医生提供了更高的精确度和灵活性。与传统方法相比，这些系统提供了手术区域的三维视图，并使器械移动具有更大的灵活性。此外，术中血管造影术和三维成像等影像技术的创新彻底改变了我们在 CABG 手术期间详细观察冠状动脉和心臟结构的能力。

冠状动脉疾病盛行率的上升和老年人口的增加也是重要的市场驱动因素。冠状动脉绕道手术对于解决脂肪堆积引起的冠状动脉阻塞至关重要。冠心病心臟疾病率的不断上升主要是由于久坐的生活方式、不良的饮食习惯和肥胖率的上升，从而推动了对 CABG 等有效治疗方案的需求。医疗保健技术的进步进一步支撑了市场，尤其是在新兴国家。对心血管治疗用聚合物修復设备製造的大量投资反映了该行业对创新和产品开发的重视。公司正在优先投资新技术和新产品，以满足心血管领域不断变化的需求。

机器人辅助微创冠状动脉绕道手术因其切口少、住院时间短、失血量少、手术精度高等优势，越来越受到人们的青睐。这一趋势正在推动对先进 CABG 设备的需求。市场医疗设施的发展也促进了 CABG 设备市场的成长。加强卫生基础设施和政府倡议（例如卫生与公众服务部的「百万心臟」倡议）旨在改善心血管护理并减少心臟病发作和中风。此类公共卫生投资凸显了对推动冠状动脉疾病治疗方案的承诺，进一步推动了市场成长。

CABG 手术的相关费用将如何阻碍冠状动脉绕道手术设备市场的成长？

CABG手术的高成本对冠状动脉绕道手术手术市场的成长构成了挑战。 CABG 是一项复杂且涉及广泛的手术，需要大量的资金投入，这可能会限制患者的就诊机会，尤其是在医疗保险和财政资源有限的地区。如此高的支出给医疗保健预算带来了巨大压力，并可能影响医疗保健系统内的整体医疗支出和护理分配。

此外，介入性心臟病学技术日益激烈的竞争也是一个主要障碍。血管成形术和支架置入术等微创手术正越来越多地被用作 CABG 的替代方案。这些手术的优点是侵入性较小、恢復时间较短，这使得患者和医疗保健提供者更喜欢这些手术，而不是传统的 CABG 手术。治疗偏好的这种变化可能会减少对 CABG 设备的需求，从而影响市场成长。 CABG手术固有的风险也限制市场的发展。这种手术可能会出现併发症，包括出血、感染和中风，这可能会阻止患者选择手术并给医疗保健提供者带来挑战。这些风险可能导致患者的治疗效果更差、医疗成本增加以及普遍不愿接受手术，进一步影响市场需求。

此外，熟练的心臟外科医生在各个地区分布不均可能会限制接受 CABG 手术的机会。在缺乏合格外科医生的地区，患者可能会面临排长队和治疗延误的问题。这些取得方面的差异可能会对病患照护产生负面影响，并减缓医疗服务不足地区 CABG 设备的普及。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章冠状动脉绕道手术设备市场（依产品类型）

• 体外循环CABG装置
• 非体外循环冠状动脉绕道手术装置
• 微创CABG设备

第五章冠状动脉绕道手术设备市场（依最终用户）

• 医院
• 心臟外科中心
• 门诊手术中心

第六章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第七章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第八章 竞争态势

• 主要企业
• 市场占有率分析

第九章 公司简介

• Terumo Cardiovascular Systems Corporation
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• Medtronic
• Abbott
• Teleflex Incorporated
• AtriCure, Inc.

第十章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十一章 市场展望 附录

• 简称列表
• 来源和参考文献

Coronary Artery Bypass Graft Devices Market Valuation - 2026-2032

The increasing aging population fuels the growth of coronary artery bypass graft devices. As people age, they become more susceptible to heart diseases, including coronary artery disease (CAD). This demographic shift contributes to a higher incidence of CAD, which in turn boosts the demand for CABG procedures and devices designed to manage and treat these conditions effectively. Thus, the growing geriatric population surge the growth of market size surpassing USD 12 Billion in 2024 to reach a valuation of USD 20.27 Billion by 2032.

Growing awareness of CAD risk factors and the importance of early detection have led to more proactive screening and diagnosis. As public understanding of heart disease improves, there is a greater emphasis on identifying risk factors early and taking preventive measures. This heightened awareness translates into increased demand for diagnostic and treatment options, including CABG devices. The combination of a rising elderly population and proactive health measures is fueli2028-2032ng the growth of the CABG devices market, as healthcare systems and patients seek advanced solutions to address and manage coronary artery disease. Thus, the increasing awareness of CAD enable the market to grow at a CAGR of 7% from 2026 to 2032.

Coronary Artery Bypass Graft Devices Market: Definition/ Overview

Coronary artery bypass graft (CABG) surgery is a crucial medical procedure designed to address coronary artery disease (CAD), a condition characterized by the narrowing or blockage of coronary arteries. This surgical intervention aims to improve blood flow to the heart muscle by creating alternative pathways for blood circulation. During the procedure, a surgeon utilizes grafts-typically healthy blood vessels taken from other parts of the patient's body, such as the leg or chest-to bypass the obstructed sections of the coronary arteries. This bypass redirects blood flow around the clogged arteries, enhancing the delivery of oxygen and nutrients to the heart muscle.

CABG surgery is performed to restore adequate blood flow to the heart, which is essential for alleviating symptoms associated with CAD, such as chest pain (angina) and shortness of breath. By improving blood circulation, the procedure also lowers the risk of stroke and reduces the likelihood of respiratory complications, offering significant benefits to patients. In cases where multiple arteries are blocked, surgeons may use single or multiple grafts to ensure optimal results.

Minimally invasive CABG techniques, which involve fewer incisions and a shorter operational time, are increasingly preferred due to their advantages, including reduced recovery time and lower risk of postoperative complications. The use of these grafts in minimally invasive surgeries helps streamline the procedure, making it less invasive while still effectively addressing the blockage and restoring healthy blood flow to the heart.

How the Innovations and Improving Patient Outcomes Surge the Growth of Coronary Artery Bypass Graft Devices Market?

Technological advancements in CABG procedures are at the forefront of this market expansion. Innovations such as robotic-assisted surgeries and endoscopic techniques have transformed cardiovascular surgery, significantly enhancing patient outcomes. These minimally invasive approaches reduce surgical trauma shorten recovery times and improve overall surgical precision. Further driving the market is the development of advanced robotic medical imaging systems, which provide surgeons with enhanced precision and dexterity. These systems offer a three-dimensional view of the surgical field and allow for greater flexibility in instrument movement compared to traditional methods. Additionally, innovations in imaging technologies, such as intraoperative angiography and three-dimensional imaging, have revolutionized the ability to visualize coronary arteries and cardiac structures in exceptional detail during CABG procedures.

The rise in coronary heart disease prevalence and the growing geriatric population are also crucial market drivers. CABG procedures are essential for addressing coronary artery blockages caused by fatty build-ups. With the increasing incidence of coronary heart disease, largely attributed to sedentary lifestyles, poor dietary habits, and rising obesity rates, there is a higher demand for effective treatment options like CABG. The market is further supported by advancements in healthcare technology, particularly in developing countries. Significant investments in the manufacture of polymer-based restorative devices for cardiovascular treatment reflect the industry's focus on innovation and product development. Companies are prioritizing investment in new technologies and products to meet the evolving needs of the cardiovascular sector.

Minimally invasive CABG surgeries, enabled by robotic assistance, have become increasingly preferred due to their benefits, including fewer incisions, reduced hospitalization periods, less blood loss, and higher surgical accuracy. This trend is pushing the demand for advanced CABG devices. The development of healthcare facilities in emerging markets is also contributing to the growth of the CABG devices market. Enhanced healthcare infrastructure and government initiatives, such as the Million Hearts initiative by the Department of Health & Human Services, aim to improve cardiovascular care and reduce heart attacks and strokes. Such public health investments underscore the commitment to advancing treatment options for coronary diseases, further boosting market growth.

How Does the Cost Associated with the CABG Procedure Impede the Growth of the Coronary Artery Bypass Graft Devices Market?

The high cost associated with CABG procedures challenges the growth of the coronary artery bypass graft devices market. As a complex and intricate surgery, CABG requires a considerable financial investment, which can limit patient access, especially in regions with limited healthcare coverage or financial resources. This high expense places a significant burden on healthcare budgets, potentially affecting the overall affordability and allocation of care within healthcare systems.

Additionally, the growing competition from interventional cardiology techniques presents a considerable restraint. Minimally invasive procedures such as angioplasty and stenting are increasingly being adopted as alternatives to CABG. These procedures offer the advantage of reduced invasiveness and shorter recovery times, which can lead patients and healthcare providers to prefer these options over traditional CABG surgery. This shift in treatment preferences can decrease the demand for CABG devices and impact market growth. The inherent risks associated with CABG surgery also play a role in restraining the market. The procedure carries potential complications, including bleeding, infection, and stroke, which can deter patients from opting for surgery and can also pose challenges for healthcare providers. These risks can lead to negative patient outcomes, increased healthcare costs, and a general reluctance to undertake the procedure, further impacting market demand.

Furthermore, the uneven distribution of skilled cardiac surgeons across different regions can limit the availability of CABG procedures. In areas where there is a shortage of qualified surgeons, patients may face long waiting lists and delays in receiving treatment. This disparity in access can adversely affect patient care and slow down the adoption of CABG devices in underserved regions.

Category-Wise Acumens

How the Minimally Invasive Nature Surge the Growth of Minimally Invasive CABG Devices Segment?

Minimally invasive CABG devices segment shows significant growth in the coronary artery bypass graft devices market. The growing popularity of off-pump coronary artery bypass grafting (CABG) is largely attributed to its minimally invasive nature, which appeals to both patients and surgeons. This approach, performed without the use of a heart-lung machine or cardiopulmonary bypass device, allows the heart to continue functioning normally during the procedure. As a result, patients experience shorter hospital stays and faster recoveries compared to traditional CABG methods. The significant benefits of off-pump CABG, including reduced post-operative complications and a lower risk of bleeding, stroke, and cardiac muscle injury, make it an attractive option for both patients and healthcare providers.

Manufacturers in the CABG devices market can leverage the growing demand for off-pump technology by investing in research and development to enhance their product offerings. The off-pump CABG segment is projected to grow at the fastest rate during the forecast period, driven by continuous innovations and advancements in this technology. These innovations focus on improving safety, efficiency, and overall patient outcomes, thereby expanding the adoption of off-pump procedures in various cardiac treatments.

As the industry moves towards greater adoption of off-pump CABG, manufacturers have a prime opportunity to capitalize on this trend. By expanding their product portfolios and investing in new technologies, they can meet the rising demand for off-pump solutions and strengthen their market position. This segment's growth reflects the broader trend towards minimally invasive surgical techniques, which aim to enhance patient care and surgical outcomes while minimizing recovery times.

How do the Advancements in Cardiovascular Surgery Foster the Growth of the Off-Pump CABG Devices Segment?

Off-pump CABG devices segment shows significant growth in the coronary artery bypass graft devices market. Off-pump coronary artery bypass grafting (CABG) represents a significant advancement in cardiovascular surgery, distinguished by its approach of performing the procedure without the use of a heart-lung machine or cardiopulmonary bypass device. This technique allows the heart to continue its normal function of supplying blood to the body during the surgery, which is a major shift from traditional methods that temporarily halt heart function.

The appeal of off-pump CABG lies in its minimally invasive nature, which offers several advantages. The procedure's reduced invasiveness leads to fewer complications, such as bleeding and stroke, and minimizes the risk of injury to the cardiac muscle. These benefits contribute to enhanced safety and efficiency, making it an attractive option for both patients and surgeons. Additionally, the reduced need for a heart-lung machine means that patients often experience shorter hospital stays and quicker recoveries compared to traditional CABG methods. This rapid recovery is a key factor driving the adoption of off-pump CABG. Manufacturers in the cardiovascular field are increasingly recognizing the potential of off-pump CABG technology. They are investing heavily in research and development to refine this approach and expand their product portfolios. The ongoing innovations by industry players further support the technology's integration into various cardiac procedures, thus propelling the segment's growth. The combination of advanced technology, reduced post-operative complications, and accelerated patient recovery positions off-pump CABG as a leading choice in the evolving landscape of coronary artery bypass surgery.Top of Form

How the Advanced Cardiac Care Infrastructure and Specialized Personnel Surge the Growth of Hospitals Segment?

The hospital segment shows significant growth in the Coronary Artery Bypass Graft Devices Market. Hospitals play a crucial role in the growth of the coronary artery bypass graft (CABG) devices market by investing in advanced cardiac care infrastructure and specialized personnel. Many hospitals are enhancing their cardiac capabilities by equipping their facilities with state-of-the-art cardiac catheterization labs, operating rooms, and intensive care units (ICUs). These upgrades include advanced monitoring and imaging technologies that support precise and effective CABG procedures.

Moreover, hospitals with dedicated cardiac surgery programs benefit from having highly skilled cardiac surgeons, anesthesiologists, and support staff who specialize in performing CABG surgeries. This specialized expertise ensures high-quality care and improves surgical outcomes. Comprehensive postoperative care is also a significant factor, with hospitals providing detailed monitoring in the ICU, effective pain management, and diligent complication management. In addition, cardiac rehabilitation services are offered to help patients recover physically and adjust their lifestyles post-surgery.

The growth in the CABG devices market is further driven by the increasing number of new heart-related cases, which boosts demand for advanced surgical interventions. Additionally, patient preference for healthcare facilities with cutting-edge infrastructure and highly experienced medical professionals contributes to this market expansion. As hospitals continue to enhance their cardiac care capabilities and attract patients seeking the best possible outcomes, the demand for CABG devices and related services is expected to rise accordingly.

Country/Region-wise Acumens

How does the Increasing Prevalence of Cardiovascular Conditions Surge the Growth of the Coronary Artery Bypass Graft Devices Market in North America?

North America is estimated to hold a significant share in the coronary artery bypass graft (CABG) devices market and is poised to maintain its dominant position throughout the forecast period driven by the increase in the global prevalence of cardiovascular conditions, such as coronary artery disease (CAD), strokes, and atrial fibrillation, driven by a rise in lifestyle-related diseases like diabetes and obesity. These health trends are leading to a greater need for CABG procedures, which in turn fuels the demand for surgical grafts and related devices.

The region is also at the forefront of innovation in cardiovascular medicine. Ongoing research efforts are focused on developing new surgical techniques, improving perioperative care, and introducing cutting-edge technologies aimed at optimizing outcomes for CABG surgeries. This commitment to advancement underscores North America's leadership in the field.

Additionally, North America's advanced healthcare infrastructure plays a critical role in sustaining market growth. The region is home to state-of-the-art hospitals and specialized cardiac centers equipped with the latest medical technologies. This high level of infrastructure supports the delivery of exceptional cardiac care and facilitates the effective implementation of advanced CABG procedures. The combination of rising cardiovascular disease prevalence, innovation in medical techniques, and robust healthcare facilities positions North America as a key player in the global CABG devices market.

How the High-Quality Healthcare Infrastructure and Sophisticated Cardiac Interventions Enable the Growth of Coronary Artery Bypass Graft Devices Market in Asia Pacific?

Asia Pacific is anticipated to witness the fastest growth in the coronary artery bypass graft devices market during the forecast period. The rise in disposable income, which allows patients to afford advanced cardiac treatments, including CABG procedures. As more individuals have the financial means to access high-quality healthcare, the demand for sophisticated cardiac interventions continues to grow. Government initiatives also play a crucial role in market expansion. Many governments are investing in healthcare development and promoting cardiovascular health through various programs and policies. These initiatives support the advancement of cardiac care and encourage the adoption of CABG procedures.

Increasing awareness about heart diseases and the importance of early treatment has led to more proactive approaches in diagnosing and managing cardiovascular conditions. This heightened awareness is contributing to early diagnosis and intervention, which drives demand for CABG surgeries and related devices. Medical tourism is another emerging trend contributing to market growth. Some countries have become popular destinations for CABG procedures due to their advanced healthcare facilities and competitive pricing. This trend attracts patients from around the world, further boosting demand for CABG devices.

Additionally, there is a growing adoption of minimally invasive CABG procedures, which offer benefits such as shorter recovery times and reduced post-operative complications. The focus on cost-effective treatment options is also increasing, as both patients and healthcare systems seek to balance quality care with financial considerations. Also, the continuous development of innovative CABG devices is enhancing the effectiveness and safety of these procedures. Advances in technology are leading to the creation of new devices that improve surgical outcomes and patient experiences, driving further growth in the market.

Competitive Landscape

The coronary artery bypass graft (CABG) devices market is characterized by a mix of established medical device companies and specialized players. While the overall market is relatively concentrated, there is ongoing competition based on factors such as product innovation, technological advancements, and geographical reach.

The organizations focus on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the Coronary Artery Bypass Graft Devices Market include:

Terumo Cardiovascular Systems Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Medtronic, Abbott, Teleflex Incorporated, AtriCure, Inc.

Latest Developments:

In August 2022, Medtronic plc announced the acquisition of Affera, Inc. This acquisition increased the company's cardiac ablation portfolio by adding its first cardiac mapping and navigation platform. The platform includes a novel, completely integrated diagnostic, focal pulsed field, and radiofrequency ablation solution.

In August 2022, the Grand Pharmaceutical Group of China invested EUR 15 million in Xeltis, a well-known medical device company with clinical-stage headquarters in the Netherlands. Grand Pharmaceutical has developed a polymer-based cardiovascular therapy device. CABG surgery uses heart valves and blood arteries with tiny diameters as restoration devices.

In January 2022, Humacyte, Inc. released data from the first preclinical investigation of the use of Humacyte's small-diameter (3.5mm) Human Acellular Vessel (HAV) in CABG at Advanced Therapies Week.

Coronary Artery Bypass Graft Devices Market, By Category

• Product Type:
• On-Pump CABG Devices
• Off-Pump CABG Devices
• Minimally Invasive CABG Devices
• End-User:
• Hospitals
• Cardiac Surgery Centers
• Ambulatory Surgical Centers
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Coronary Artery Bypass Graft Devices Market, By Product Type

• On-pump CABG devices
• Off-pump CABG devices
• Minimally invasive CABG devices

5. Coronary Artery Bypass Graft Devices Market, By End-User

• Hospitals
• Cardiac surgery centers
• Ambulatory surgical centers

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• Terumo Cardiovascular Systems Corporation
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• Medtronic
• Abbott
• Teleflex Incorporated
• AtriCure, Inc.

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References